The Global Bone Densitometer Devices Market is set for significant growth, with its valuation expected to surpass USD 347.7 million in 2023 and reach USD 525.0 million by 2033. Expanding at a Compound Annual Growth Rate (CAGR) of 4.2% from 2023 to 2033, this market is witnessing robust demand as bone health diagnostics become increasingly critical for assessing and managing bone-related diseases.
Bone densitometer devices perform non-invasive procedures to assess bone density and measure bone strength, helping to diagnose and monitor conditions such as osteoporosis and other bone disorders. These devices are essential for analyzing the risk of fractures and other bone-related complications, making them indispensable tools in preventative and diagnostic healthcare.
According to the International Osteoporosis Foundation, the incidence of hip fractures in men is expected to increase by more than 300% and will increase by 240% in women by 2050. Hence, the high prevalence of osteoporosis and bone-related diseases such as osteopenia, osteomalacia, and osteoporotic fractures will drive the demand for bone assessment, boosting the bone densitometer devices market.
Key Insights and Market Trends:
- Market Valuation: Estimated to surpass US$ 347.7 million in 2023, with growth projected to reach US$ 525.0 million by 2033.
- CAGR: Expected to grow at a 4.2% CAGR over the forecast period.
- Growth Drivers: Increasing prevalence of osteoporosis and other bone-related diseases, growing elderly population, and rising demand for early diagnostic solutions.
As the need for bone health diagnostics rises globally, bone densitometer devices are positioned to play a crucial role in preventative healthcare and disease management, aiding in timely diagnosis and reducing the risk of bone-related complications. The anticipated market growth underscores the expanding role of these devices in the global healthcare landscape.
Competitive Landscape
Key players in the market are focused on enhancing product features to strengthen their position in the bone densitometer devices market, and also to expand their footprint in emerging markets. The key strategy adopted by manufacturers to lead in the market is the acquisition & distribution agreement of other companies to expand their business.
For instance:
- In June 2022, Echolight Medical LLC announced the launching of the commercial sale of a novel radiofrequency echographic multi spectrometry (REMS) which is a radiation-free bone densitometer and the first portable, that provides detailed profiling of patient’s bone health scores
- In May 2019, Hologic Inc. disclosed its agreement with DEXA+ to distribute the DXA system for calculating body composition. Through the partnership, Hologic was able to broaden the application of its industry-leading DXA system as well as its expertise in body composition analysis.
Recent Developments Observed by FMI:
- In April 2022, Newman Regional Health added the Hologic Horizon DXA bone densitometry device, enhancing its range of health and wellness offerings for both men and women.
- The first DEXA-C implantation was conducted by Aurora Spine Corporation in March 2022 at Cypress Pointe Surgical Hospital in Louisiana, where the implant density was precisely matched to the patient’s bone quality.
Key Companies Profiled
GE Healthcare; Hologic, Inc.; OSI Systems, Inc.; Diagnostic Medical Systems Group; Swissray Global Healthcare Holding, Ltd.; BeamMed, Ltd.; Echolight S.P.A; Scanflex Healthcare AB; Medonica Co., Ltd.; Eurotec Systems S.r.l; AMPall Co., Ltd.; L’acn L’accessorio Nucleare S.R.L; Shenzhen XRAY Electric Co., Ltd.; YOZMA BMTech Co., Ltd.; Nanoomtech Co., Ltd.; Osteosys Corporation; FURUNO Electric Co., Ltd.; XinGaoYi Co., Ltd.; Anjue Medical Equipment; Trivitron Healthcare
Full Report Revealed
Bone Densitometer Devices Market Segmentation
By Product:
- Peripheral Bone Densitometer
- Axial Bone Densitometer
By Technology:
- Dual Energy X-Ray Absorptiometry (DXA)
- Peripheral Dual Energy X-Ray
- Absorptiometry (pDXA)
- Quantitative Ultrasound (QUS)
- Others
By End-User:
- Hospitals
- Orthopedic Clinics
- Diagnostic Centers
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube